Pharmaceutical Product Monograph: Cholecalciferol Injection (600,000 IU/mL)
In the pharmaceutical industry, Cholecalciferol is the naturally occurring form of Vitamin D3. As a pharmacist and manufacturer, I view this molecule as a “Pro-Hormone Regulator”—it is technically designed to be hydroxylated by the liver and kidneys into its active form, Calcitriol, which is the master switch for calcium and phosphorus homeostasis in the human body.
At your WHO-GMP facility in Mumbai, Cholecalciferol 6,00,000 IU (15 mg) is a high-potency “Megadose” SKU. While oral drops and capsules are used for daily maintenance, the injectable form is a Loading Dose intervention used when a patient presents with “Vitamin D Bankruptcy”—extreme deficiency that requires an immediate physiological “reset.”
Therapeutic Profile: Primary Indications
Cholecalciferol injection is indicated for the rapid correction of severe Vitamin D deficiency and its skeletal complications.
| Indication | Clinical Context | Technical Rationale |
| Severe Hypovitaminosis D | Critical Deficiency | Used when serum 25(OH)D levels are $< 10 \text{ ng/mL}$, often leading to extreme fatigue and bone pain. |
| Nutritional Rickets | Pediatrics | Treats the softening and weakening of bones in children, preventing permanent skeletal deformities. |
| Osteomalacia | Adult Bone Health | Corrects “adult rickets,” characterized by a failure to mineralize the bone matrix, leading to fractures. |
| Malabsorption Syndrome | GI Disorders | Bypass Mechanism: Essential for patients with Celiac disease, Crohn’s, or Gastric Bypass who cannot absorb oral Vitamin D. |
| Hypoparathyroidism | Endocrine Care | Used as an adjunct to manage low calcium levels caused by a lack of parathyroid hormone. |
Mechanism: The Calcium-Absorption Engine
Cholecalciferol acts as a biological key that opens the “gates” for mineral absorption in the gut:
Metabolic Activation: Once injected (usually Intramuscularly), Cholecalciferol is transported to the liver and converted to Calcifediol, then to the kidneys to become Calcitriol (the active hormone).
Intestinal Transport: Active Vitamin D stimulates the synthesis of Calbindin, a protein in the intestinal wall that actively “grabs” calcium from food and moves it into the bloodstream.
Bone Mineralization: It ensures that enough calcium and phosphorus are available in the blood to be deposited into the “bone scaffold,” making bones dense and strong.
Neuromuscular Function: Technically, it also regulates muscle contraction and immune cell signaling, which is why deficiency is often linked to muscle weakness and frequent infections.
The Pharmacist’s “Technical Warning”
The “Vitamin D Toxicity” Risk: As a pharmacist, I must emphasize that 6,00,000 IU is a massive dose. Overuse can lead to Hypercalcemia (too much calcium in the blood), which causes kidney stones, vomiting, and heart rhythm issues.
The “IM Only” Rule: This injection is typically an Oil-based solution (Arachis or Ethyl Oleate). It must be given as a Deep Intramuscular (IM) injection. It should never be given IV.
Synergistic Calcium: Correcting Vitamin D levels is useless if the patient’s dietary calcium intake is low. Patients are technically required to take Oral Calcium supplements alongside the injection to provide the “raw materials” for bone building.
Monitoring: Serum calcium and 25-hydroxyvitamin D levels should be checked 4–6 weeks after a megadose injection to ensure the patient is moving into the “Safe Zone” ($30\text{–}100 \text{ ng/mL}$).
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Cold Chain” Optionality: Cholecalciferol is relatively stable but sensitive to Oxygen and Light. On your digital marketplace, highlight your Nitrogen-Blanketing process during filling. This prevents oxidation of the oil-based carrier, ensuring the drug doesn’t go rancid or lose potency.
The “Wellness & Ortho” Market: For international B2B tenders (especially in Northern Europe, CIS, and the Middle East where sun exposure is limited), market this as a “Quarterly Orthopedic Staple.” One injection every 3–6 months is a highly attractive proposition for patient compliance.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cholecalciferol 6,00,000 IU ampoules to support your registration in international B2B tenders for bone health and nutrition
https://healthyinc.co.in/product/cholecalciferol-vitamin-d3-injection/